These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 7791960)

  • 41. [Endothelin 3 (ET3) stimulates the hypothalamic-pituitary-adrenal axis mainly by corticotropin-releasing-hormone (CRH)].
    Hirai M; Ooya E; Miyanaga K; Saito Y; Kishida S; Miyabo S; Nakai T
    Nihon Naibunpi Gakkai Zasshi; 1991 Dec; 67(12):1345-55. PubMed ID: 1664369
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Combined hypervolemia and hypoosmolality alter hypothalamic-pituitary-adrenal axis response to endotoxin stimulation.
    Dadoun F; Velut JG; Guillaume V; Sauze N; Orsoni JC; Gaillard RC; Oliver CC
    Neuroendocrinology; 1999 May; 69(5):352-9. PubMed ID: 10343176
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Stimulation of adrenocorticotropin secretion by insulin-induced hypoglycemia in the developing rat involves arginine vasopressin but not corticotropin-releasing factor.
    Muret L; Priou A; Oliver C; Grino M
    Endocrinology; 1992 May; 130(5):2725-32. PubMed ID: 1315256
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of fetal ethanol exposure on pituitary-adrenal sensitivity to secretagogues.
    Osborn JA; Yu C; Stelzl GE; Weinberg J
    Alcohol Clin Exp Res; 2000 Jul; 24(7):1110-9. PubMed ID: 10924017
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nitric oxide mediates the interleukin-1beta- and nicotine-induced hypothalamic-pituitary-adrenocortical response during social stress.
    Gadek-Michalska A; Bugajski J
    J Physiol Pharmacol; 2005 Sep; 56(3):491-503. PubMed ID: 16204770
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Stimulation by peptide histidine methionine (PHM) of adrenocorticotropin secretion in patients with Cushing's disease: a comparison with the effect of vasoactive intestinal peptide (VIP) and a study on the effect of combined administration of corticotropin-releasing hormone with PHM or VIP.
    Watanobe H; Tamura T
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1372-7. PubMed ID: 8200939
    [TBL] [Abstract][Full Text] [Related]  

  • 47. ACTH releasing activity of KP-102 (GHRP-2) in rats is mediated mainly by release of CRF.
    Hirotani C; Oki Y; Ukai K; Okuno T; Kurasaki S; Ohyama T; Doi N; Sasaki K; Ase K
    Naunyn Schmiedebergs Arch Pharmacol; 2005 Jan; 371(1):54-60. PubMed ID: 15645295
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Corticotrophin-releasing factor mediates vasoactive intestinal peptide-induced hypophagia and changes in plasma parameters.
    Garnica-Siqueira MC; Martins AB; Zaia DAM; Leite CM; Uchôa ET; Zaia CTBV
    Horm Behav; 2018 Sep; 105():138-145. PubMed ID: 30138609
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adrenergic regulation of the hypothalamic-pituitary-adrenal axis under basal and social stress conditions.
    Bugajski J; Gadek-Michalska A; Ołowska A; Borycz J; Głód R; Bugajski AJ
    J Physiol Pharmacol; 1995 Sep; 46(3):297-312. PubMed ID: 8527811
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vasopressin and oxytocin: hypothalamic modulators of the stress response: a review.
    Gibbs DM
    Psychoneuroendocrinology; 1986; 11(2):131-9. PubMed ID: 3018820
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In the rat, endogenous nitric oxide modulates the response of the hypothalamic-pituitary-adrenal axis to interleukin-1 beta, vasopressin, and oxytocin.
    Rivier C; Shen GH
    J Neurosci; 1994 Apr; 14(4):1985-93. PubMed ID: 8158253
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact of repeated stressor exposure on the release of corticotropin-releasing hormone, arginine-vasopressin and bombesin-like peptides at the anterior pituitary.
    Merali Z; Hayley S; Kent P; McIntosh J; Bédard T; Anisman H
    Behav Brain Res; 2009 Mar; 198(1):105-12. PubMed ID: 19014976
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of excitatory amino acid transmitters on hypothalamic corticotropin-releasing hormone (CRH) and arginine-vasopressin (AVP) release in vitro: implications in pituitary-adrenal regulation.
    Patchev VK; Karalis K; Chrousos GP
    Brain Res; 1994 Jan; 633(1-2):312-6. PubMed ID: 7907936
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Alprazolam attenuates vasopressin-stimulated adrenocorticotropin and cortisol release: evidence for synergy between vasopressin and corticotropin-releasing hormone in humans.
    Torpy DJ; Grice JE; Hockings GI; Walters MM; Crosbie GV; Jackson RV
    J Clin Endocrinol Metab; 1994 Jul; 79(1):140-4. PubMed ID: 8027217
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The influence of corticosteroids on the secretion of corticotrophin and its hypothalamic releasing hormone.
    Buckingham JC
    J Physiol; 1979 Jan; 286():331-42. PubMed ID: 220413
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of interleukin 1beta on the HPA axis in H1-receptor knockout mice.
    Toftegaard CL; Knigge U; Kjaer A; Watanabe T; Friis-Hansen L; Warberg J
    Neuroimmunomodulation; 2002-2003; 10(6):344-50. PubMed ID: 12907841
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Stimulation of the hypothalamo-pituitary-adrenal axis in the rat by three selective type-4 phosphodiesterase inhibitors: in vitro and in vivo studies.
    Kumari M; Cover PO; Poyser RH; Buckingham JC
    Br J Pharmacol; 1997 Jun; 121(3):459-68. PubMed ID: 9179387
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Peptide histidine isoleucine-induced elevations in ACTH and corticosterone in the rat.
    Alexander LD; Sander LD; Hooper T; Washington V
    Peptides; 1994; 15(6):1021-5. PubMed ID: 7991444
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Stimulation of CRH-mediated ACTH secretion by central administration of neurotensin: evidence for the participation of the paraventricular nucleus.
    Rowe W; Viau V; Meaney MJ; Quirion R
    J Neuroendocrinol; 1995 Feb; 7(2):109-17. PubMed ID: 7767323
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Stimulation of the hypothalamo-pituitary-adrenal axis in the rat by the type 4 phosphodiesterase (PDE-4) inhibitor, denbufylline.
    Hadley AJ; Kumari M; Cover PO; Osborne J; Poyser R; Flack JD; Buckingham JC
    Br J Pharmacol; 1996 Oct; 119(3):463-70. PubMed ID: 8894165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.